Mon, December 11, 2023

Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $85 on, Dec 11th, 2023

Andrew Fein of HC Wainwright & Co., Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $85 on, Dec 11th, 2023.

Andrew has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $58 on, Friday, October 27th, 2023


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023
  • Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023